Hexal AG
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Subsidiary
- Established
- 1986-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.hexal.de
Clinical Trials
108
Active:93
Completed:13
Trial Phases
3 Phases
Phase 1:58
Phase 3:3
Not Applicable:1
Drug Approvals
45
SFDA:20
NMPA:13
PHILIPPINES:7
+1 more agencies
Drug Approvals
Irbesartan and Hydrochlorothiazide Tablets
- Product Name
- 厄贝沙坦氢氯噻嗪片
- Approval Number
- 国药准字HJ20240030
- Approval Date
- May 28, 2024
NMPA
Moxifloxacin Hydrochloride Tablets
- Product Name
- 盐酸莫西沙星片
- Approval Number
- 国药准字HJ20210032
- Approval Date
- May 19, 2021
NMPA
Bisoprolol Fumarate Tablets
- Product Name
- 富马酸比索洛尔片
- Approval Number
- 国药准字HJ20170259
- Approval Date
- Jan 5, 2021
NMPA
Bisoprolol Fumarate Tablets
- Product Name
- 富马酸比索洛尔片
- Approval Number
- 国药准字HJ20170261
- Approval Date
- Jan 5, 2021
NMPA
Clopidogrel Bisulfate Tablets
- Product Name
- 硫酸氢氯吡格雷片
- Approval Number
- 国药准字HJ20200049
- Approval Date
- Nov 24, 2020
NMPA
- Prev
- 1
- 2
- Next
Clinical Trials
Distribution across different clinical trial phases (62 trials with phase data)• Click on a phase to view related trials
Phase 1
58 (93.5%)Phase 3
3 (4.8%)Not Applicable
1 (1.6%)No trials found
News
No news found